Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Launched by ROM TECHNOLOGIES, INC · Jul 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help patients recover from heart issues, like heart attacks or heart surgery, by combining home-based rehabilitation with telemedicine. This means that instead of going to a hospital or clinic for rehabilitation, patients can do their exercises and receive support from therapists at home through video calls. The trial will look at how well this approach works in improving patients' quality of life, managing their health (like diet and blood pressure), and encouraging them to stick with the program.
To participate, individuals need to be over 18 years old and have recently undergone a procedure to treat their heart condition, such as surgery or a stent placement. They should also be in a relatively stable condition, meaning they are not experiencing severe heart problems. Participants can expect to engage in exercise training at home while receiving guidance and support from their therapists via telemedicine. This trial is currently recruiting participants and is open to all genders, so if you or someone you know fits the criteria, this could be a great opportunity for heart health improvement.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Over the age of 18
- • 2. NYHA Functional Class I, II,
- • 3. Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation)
- • 4. Candidate for traditional center-based cardiac rehabilitation
- Exclusion Criteria:
- • 1. Under the age of 18
- • 2. Adults lacking capacity to consent.
- • 3. NYHA Functional Class III, IV
- • 4. Acute coronary syndrome
- • 5. Systolic heart failure (LV EF \<40%)
- • 6. Status post cardiac surgery for structural heart disease or heart transplant
- • 7. Percutaneous coronary angioplasty
- • 8. Adults lacking capacity to consent.
- • 9. Pregnant women
About Rom Technologies, Inc
Rom Technologies, Inc. is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on leveraging cutting-edge technology and robust scientific methodologies, the company specializes in conducting clinical trials that aim to evaluate the safety and efficacy of novel therapeutics. Committed to maintaining the highest ethical standards and regulatory compliance, Rom Technologies collaborates with a network of healthcare professionals and institutions to ensure rigorous data collection and analysis. By fostering partnerships and utilizing state-of-the-art solutions, Rom Technologies strives to bring transformative treatments to market, ultimately enhancing patient outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brookfield, Connecticut, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported